世界の壊死性腸炎治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Necrotic Enteritis Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4043
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、壊死性腸炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（インターアルファ阻害タンパク質、抗生物質）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・壊死性腸炎治療薬の市場動向
・企業の競争状況、市場シェア
・壊死性腸炎治療薬の種類別市場規模（インターアルファ阻害タンパク質、抗生物質）
・壊死性腸炎治療薬の用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）
・壊死性腸炎治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・壊死性腸炎治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・壊死性腸炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・壊死性腸炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・壊死性腸炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Prometic Life Sciences、BioGaia Probiotics、Fresenius、Teva、Bayer、Alcon、GlaxoSmithKline）
・結論

Necrotic enteritis also called as necrotizing enterocolitis is inflammatory bowel disease found prematurely born infants.

Market Analysis and Insights: Global Necrotic Enteritis Drug Market
The global Necrotic Enteritis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Necrotic Enteritis Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Necrotic Enteritis Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Necrotic Enteritis Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Necrotic Enteritis Drug market.

Global Necrotic Enteritis Drug Scope and Market Size
Necrotic Enteritis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Necrotic Enteritis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Inter Alpha Inhibitor Proteins
Antibiotics

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Prometic Life Sciences
BioGaia Probiotics
Fresenius
Teva
Bayer
Alcon
GlaxoSmithKline

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Necrotic Enteritis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Inter Alpha Inhibitor Proteins
1.2.3 Antibiotics
1.3 Market by Application
1.3.1 Global Necrotic Enteritis Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Necrotic Enteritis Drug Market Perspective (2016-2027)
2.2 Necrotic Enteritis Drug Growth Trends by Regions
2.2.1 Necrotic Enteritis Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Necrotic Enteritis Drug Historic Market Share by Regions (2016-2021)
2.2.3 Necrotic Enteritis Drug Forecasted Market Size by Regions (2022-2027)
2.3 Necrotic Enteritis Drug Industry Dynamic
2.3.1 Necrotic Enteritis Drug Market Trends
2.3.2 Necrotic Enteritis Drug Market Drivers
2.3.3 Necrotic Enteritis Drug Market Challenges
2.3.4 Necrotic Enteritis Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Necrotic Enteritis Drug Players by Revenue
3.1.1 Global Top Necrotic Enteritis Drug Players by Revenue (2016-2021)
3.1.2 Global Necrotic Enteritis Drug Revenue Market Share by Players (2016-2021)
3.2 Global Necrotic Enteritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Necrotic Enteritis Drug Revenue
3.4 Global Necrotic Enteritis Drug Market Concentration Ratio
3.4.1 Global Necrotic Enteritis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Necrotic Enteritis Drug Revenue in 2020
3.5 Necrotic Enteritis Drug Key Players Head office and Area Served
3.6 Key Players Necrotic Enteritis Drug Product Solution and Service
3.7 Date of Enter into Necrotic Enteritis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Necrotic Enteritis Drug Breakdown Data by Type
4.1 Global Necrotic Enteritis Drug Historic Market Size by Type (2016-2021)
4.2 Global Necrotic Enteritis Drug Forecasted Market Size by Type (2022-2027)

5 Necrotic Enteritis Drug Breakdown Data by Application
5.1 Global Necrotic Enteritis Drug Historic Market Size by Application (2016-2021)
5.2 Global Necrotic Enteritis Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Necrotic Enteritis Drug Market Size (2016-2027)
6.2 North America Necrotic Enteritis Drug Market Size by Type
6.2.1 North America Necrotic Enteritis Drug Market Size by Type (2016-2021)
6.2.2 North America Necrotic Enteritis Drug Market Size by Type (2022-2027)
6.2.3 North America Necrotic Enteritis Drug Market Size by Type (2016-2027)
6.3 North America Necrotic Enteritis Drug Market Size by Application
6.3.1 North America Necrotic Enteritis Drug Market Size by Application (2016-2021)
6.3.2 North America Necrotic Enteritis Drug Market Size by Application (2022-2027)
6.3.3 North America Necrotic Enteritis Drug Market Size by Application (2016-2027)
6.4 North America Necrotic Enteritis Drug Market Size by Country
6.4.1 North America Necrotic Enteritis Drug Market Size by Country (2016-2021)
6.4.2 North America Necrotic Enteritis Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Necrotic Enteritis Drug Market Size (2016-2027)
7.2 Europe Necrotic Enteritis Drug Market Size by Type
7.2.1 Europe Necrotic Enteritis Drug Market Size by Type (2016-2021)
7.2.2 Europe Necrotic Enteritis Drug Market Size by Type (2022-2027)
7.2.3 Europe Necrotic Enteritis Drug Market Size by Type (2016-2027)
7.3 Europe Necrotic Enteritis Drug Market Size by Application
7.3.1 Europe Necrotic Enteritis Drug Market Size by Application (2016-2021)
7.3.2 Europe Necrotic Enteritis Drug Market Size by Application (2022-2027)
7.3.3 Europe Necrotic Enteritis Drug Market Size by Application (2016-2027)
7.4 Europe Necrotic Enteritis Drug Market Size by Country
7.4.1 Europe Necrotic Enteritis Drug Market Size by Country (2016-2021)
7.4.2 Europe Necrotic Enteritis Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Necrotic Enteritis Drug Market Size (2016-2027)
8.2 Asia-Pacific Necrotic Enteritis Drug Market Size by Type
8.2.1 Asia-Pacific Necrotic Enteritis Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Necrotic Enteritis Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Necrotic Enteritis Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Necrotic Enteritis Drug Market Size by Application
8.3.1 Asia-Pacific Necrotic Enteritis Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Necrotic Enteritis Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Necrotic Enteritis Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Necrotic Enteritis Drug Market Size by Region
8.4.1 Asia-Pacific Necrotic Enteritis Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Necrotic Enteritis Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Necrotic Enteritis Drug Market Size (2016-2027)
9.2 Latin America Necrotic Enteritis Drug Market Size by Type
9.2.1 Latin America Necrotic Enteritis Drug Market Size by Type (2016-2021)
9.2.2 Latin America Necrotic Enteritis Drug Market Size by Type (2022-2027)
9.2.3 Latin America Necrotic Enteritis Drug Market Size by Type (2016-2027)
9.3 Latin America Necrotic Enteritis Drug Market Size by Application
9.3.1 Latin America Necrotic Enteritis Drug Market Size by Application (2016-2021)
9.3.2 Latin America Necrotic Enteritis Drug Market Size by Application (2022-2027)
9.3.3 Latin America Necrotic Enteritis Drug Market Size by Application (2016-2027)
9.4 Latin America Necrotic Enteritis Drug Market Size by Country
9.4.1 Latin America Necrotic Enteritis Drug Market Size by Country (2016-2021)
9.4.2 Latin America Necrotic Enteritis Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Necrotic Enteritis Drug Market Size (2016-2027)
10.2 Middle East & Africa Necrotic Enteritis Drug Market Size by Type
10.2.1 Middle East & Africa Necrotic Enteritis Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Necrotic Enteritis Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Necrotic Enteritis Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Necrotic Enteritis Drug Market Size by Application
10.3.1 Middle East & Africa Necrotic Enteritis Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Necrotic Enteritis Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Necrotic Enteritis Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Necrotic Enteritis Drug Market Size by Country
10.4.1 Middle East & Africa Necrotic Enteritis Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Necrotic Enteritis Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Prometic Life Sciences
11.1.1 Prometic Life Sciences Company Details
11.1.2 Prometic Life Sciences Business Overview
11.1.3 Prometic Life Sciences Necrotic Enteritis Drug Introduction
11.1.4 Prometic Life Sciences Revenue in Necrotic Enteritis Drug Business (2016-2021)
11.1.5 Prometic Life Sciences Recent Development
11.2 BioGaia Probiotics
11.2.1 BioGaia Probiotics Company Details
11.2.2 BioGaia Probiotics Business Overview
11.2.3 BioGaia Probiotics Necrotic Enteritis Drug Introduction
11.2.4 BioGaia Probiotics Revenue in Necrotic Enteritis Drug Business (2016-2021)
11.2.5 BioGaia Probiotics Recent Development
11.3 Fresenius
11.3.1 Fresenius Company Details
11.3.2 Fresenius Business Overview
11.3.3 Fresenius Necrotic Enteritis Drug Introduction
11.3.4 Fresenius Revenue in Necrotic Enteritis Drug Business (2016-2021)
11.3.5 Fresenius Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Necrotic Enteritis Drug Introduction
11.4.4 Teva Revenue in Necrotic Enteritis Drug Business (2016-2021)
11.4.5 Teva Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Necrotic Enteritis Drug Introduction
11.5.4 Bayer Revenue in Necrotic Enteritis Drug Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Alcon
11.6.1 Alcon Company Details
11.6.2 Alcon Business Overview
11.6.3 Alcon Necrotic Enteritis Drug Introduction
11.6.4 Alcon Revenue in Necrotic Enteritis Drug Business (2016-2021)
11.6.5 Alcon Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Necrotic Enteritis Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Necrotic Enteritis Drug Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Necrotic Enteritis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Inter Alpha Inhibitor Proteins
Table 3. Key Players of Antibiotics
Table 4. Global Necrotic Enteritis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Necrotic Enteritis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Necrotic Enteritis Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Necrotic Enteritis Drug Market Share by Regions (2016-2021)
Table 8. Global Necrotic Enteritis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Necrotic Enteritis Drug Market Share by Regions (2022-2027)
Table 10. Necrotic Enteritis Drug Market Trends
Table 11. Necrotic Enteritis Drug Market Drivers
Table 12. Necrotic Enteritis Drug Market Challenges
Table 13. Necrotic Enteritis Drug Market Restraints
Table 14. Global Necrotic Enteritis Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Necrotic Enteritis Drug Market Share by Players (2016-2021)
Table 16. Global Top Necrotic Enteritis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotic Enteritis Drug as of 2020)
Table 17. Ranking of Global Top Necrotic Enteritis Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Necrotic Enteritis Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Necrotic Enteritis Drug Product Solution and Service
Table 21. Date of Enter into Necrotic Enteritis Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Necrotic Enteritis Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Necrotic Enteritis Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Necrotic Enteritis Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Necrotic Enteritis Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Necrotic Enteritis Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Necrotic Enteritis Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Necrotic Enteritis Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Necrotic Enteritis Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Necrotic Enteritis Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Necrotic Enteritis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Necrotic Enteritis Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Necrotic Enteritis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Necrotic Enteritis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Necrotic Enteritis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Necrotic Enteritis Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Necrotic Enteritis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Necrotic Enteritis Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Necrotic Enteritis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Necrotic Enteritis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Necrotic Enteritis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Necrotic Enteritis Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Necrotic Enteritis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Necrotic Enteritis Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Necrotic Enteritis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Necrotic Enteritis Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Necrotic Enteritis Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Necrotic Enteritis Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Necrotic Enteritis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Necrotic Enteritis Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Necrotic Enteritis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Necrotic Enteritis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Necrotic Enteritis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Necrotic Enteritis Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Necrotic Enteritis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Necrotic Enteritis Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Necrotic Enteritis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Necrotic Enteritis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Necrotic Enteritis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Prometic Life Sciences Company Details
Table 62. Prometic Life Sciences Business Overview
Table 63. Prometic Life Sciences Necrotic Enteritis Drug Product
Table 64. Prometic Life Sciences Revenue in Necrotic Enteritis Drug Business (2016-2021) & (US$ Million)
Table 65. Prometic Life Sciences Recent Development
Table 66. BioGaia Probiotics Company Details
Table 67. BioGaia Probiotics Business Overview
Table 68. BioGaia Probiotics Necrotic Enteritis Drug Product
Table 69. BioGaia Probiotics Revenue in Necrotic Enteritis Drug Business (2016-2021) & (US$ Million)
Table 70. BioGaia Probiotics Recent Development
Table 71. Fresenius Company Details
Table 72. Fresenius Business Overview
Table 73. Fresenius Necrotic Enteritis Drug Product
Table 74. Fresenius Revenue in Necrotic Enteritis Drug Business (2016-2021) & (US$ Million)
Table 75. Fresenius Recent Development
Table 76. Teva Company Details
Table 77. Teva Business Overview
Table 78. Teva Necrotic Enteritis Drug Product
Table 79. Teva Revenue in Necrotic Enteritis Drug Business (2016-2021) & (US$ Million)
Table 80. Teva Recent Development
Table 81. Bayer Company Details
Table 82. Bayer Business Overview
Table 83. Bayer Necrotic Enteritis Drug Product
Table 84. Bayer Revenue in Necrotic Enteritis Drug Business (2016-2021) & (US$ Million)
Table 85. Bayer Recent Development
Table 86. Alcon Company Details
Table 87. Alcon Business Overview
Table 88. Alcon Necrotic Enteritis Drug Product
Table 89. Alcon Revenue in Necrotic Enteritis Drug Business (2016-2021) & (US$ Million)
Table 90. Alcon Recent Development
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Necrotic Enteritis Drug Product
Table 94. GlaxoSmithKline Revenue in Necrotic Enteritis Drug Business (2016-2021) & (US$ Million)
Table 95. GlaxoSmithKline Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Necrotic Enteritis Drug Market Share by Type: 2020 VS 2027
Figure 2. Inter Alpha Inhibitor Proteins Features
Figure 3. Antibiotics Features
Figure 4. Global Necrotic Enteritis Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Online Pharmacy Case Studies
Figure 8. Necrotic Enteritis Drug Report Years Considered
Figure 9. Global Necrotic Enteritis Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Necrotic Enteritis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Necrotic Enteritis Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Necrotic Enteritis Drug Market Share by Regions (2022-2027)
Figure 13. Global Necrotic Enteritis Drug Market Share by Players in 2020
Figure 14. Global Top Necrotic Enteritis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotic Enteritis Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Necrotic Enteritis Drug Revenue in 2020
Figure 16. Global Necrotic Enteritis Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Necrotic Enteritis Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Necrotic Enteritis Drug Market Share by Type (2016-2027)
Figure 20. North America Necrotic Enteritis Drug Market Share by Application (2016-2027)
Figure 21. North America Necrotic Enteritis Drug Market Share by Country (2016-2027)
Figure 22. United States Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Necrotic Enteritis Drug Market Share by Type (2016-2027)
Figure 26. Europe Necrotic Enteritis Drug Market Share by Application (2016-2027)
Figure 27. Europe Necrotic Enteritis Drug Market Share by Country (2016-2027)
Figure 28. Germany Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Necrotic Enteritis Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Necrotic Enteritis Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Necrotic Enteritis Drug Market Share by Region (2016-2027)
Figure 38. China Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Necrotic Enteritis Drug Market Share by Type (2016-2027)
Figure 46. Latin America Necrotic Enteritis Drug Market Share by Application (2016-2027)
Figure 47. Latin America Necrotic Enteritis Drug Market Share by Country (2016-2027)
Figure 48. Mexico Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Necrotic Enteritis Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Necrotic Enteritis Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Necrotic Enteritis Drug Market Share by Country (2016-2027)
Figure 54. Turkey Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Necrotic Enteritis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Prometic Life Sciences Revenue Growth Rate in Necrotic Enteritis Drug Business (2016-2021)
Figure 58. BioGaia Probiotics Revenue Growth Rate in Necrotic Enteritis Drug Business (2016-2021)
Figure 59. Fresenius Revenue Growth Rate in Necrotic Enteritis Drug Business (2016-2021)
Figure 60. Teva Revenue Growth Rate in Necrotic Enteritis Drug Business (2016-2021)
Figure 61. Bayer Revenue Growth Rate in Necrotic Enteritis Drug Business (2016-2021)
Figure 62. Alcon Revenue Growth Rate in Necrotic Enteritis Drug Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Necrotic Enteritis Drug Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の感染性腸炎治療市場規模・現状・予測（2021年-2027年）

Global Infectious Enteritis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3149 2021年4月 95Pages
QYResearch社発行の本調査資料では、感染性腸炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、アンピシリン、クロラムフェニコール、その他）、用途別市場規模（病院薬局、オンライン薬局、薬局、その他）、主要地域別市場規模（北米...

世界の小売薬市場規模・現状・予測（2021年-2027年）

Global Retail Drug Market Size, Status and Forecast 2021-2027
QYR2104Z5016 2021年4月 96Pages
QYResearch社発行の本調査資料では、小売薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ジェネリック医薬品、OTC医薬品、その他）、用途別市場規模（病院、診療所、家庭用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界のドラッグデリバリーにおけるナノテクノロジー市場規模・現状・予測（2021年-2027年）

Global Nanotechnology in Drug Delivery Market Size, Status and Forecast 2021-2027
QYR2104Z4016 2021年4月 91Pages
QYResearch社発行の本調査資料では、ドラッグデリバリーにおけるナノテクノロジーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（標的化送達、薬剤パッケージ）、用途別市場規模（がん、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のアレルギー性鼻炎治療薬市場規模・現状・予測（2021年-2027年）

Global Allergy Rhinitis Drug Market Size, Status and Forecast 2021-2027
QYR2104Z0246 2021年4月 95Pages
QYResearch社発行の本調査資料では、アレルギー性鼻炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、スプレー）、用途別市場規模（病院、クリニック、医療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の薬物乱用検査サービス市場規模・現状・予測（2021年-2027年）

Global Drug of Abuse Testing Services Market Size, Status and Forecast 2021-2027
QYR2104Z1989 2021年4月 92Pages
QYResearch社発行の本調査資料では、薬物乱用検査サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルコール、大麻、コカイン、オピオイド、アンフェタミン、LSD、その他）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模...

世界のドラッグリポジショニング市場規模・現状・予測（2021年-2027年）

Global Drug Repurposing Market Size, Status and Forecast 2021-2027
QYR2104Z1992 2021年4月 96Pages
QYResearch社発行の本調査資料では、ドラッグリポジショニングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍、中枢神経系疾患、神経変性疾患、その他）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリ...

世界のドラッグデリバリーにおけるナノテクノロジー市場規模・現状・予測（2021年-2027年）

世界のドラッグデリバリー市場規模・現状・予測（2021年-2027年）

Global Drug Discovery Market Size, Status and Forecast 2021-2027
QYR2104Z1983 2021年4月 99Pages
QYResearch社発行の本調査資料では、ドラッグデリバリーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（小分子薬、生物製剤）、用途別市場規模（研究所、製薬会社、バイオテクノロジー会社）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のドラッグリポジショニング市場規模・現状・予測（2021年-2027年）

Global Drug Repositioning Market Size, Status and Forecast 2021-2027
QYR2104Z1990 2021年4月 98Pages
QYResearch社発行の本調査資料では、ドラッグリポジショニングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈内）、用途別市場規模（中枢神経障害、心血管障害、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界のドラッグリプロファイリング市場規模・現状・予測（2021年-2027年）

Global Drug Reprofiling Market Size, Status and Forecast 2021-2027
QYR2104Z1991 2021年4月 90Pages
QYResearch社発行の本調査資料では、ドラッグリプロファイリングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈内）、用途別市場規模（中枢神経障害、心血管障害、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の感染性腸炎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Infectious Enteritis Treatment Market The global Infectious Enteritis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界の強皮症治療薬市場規模・現状・予測（2021年-2027年） Scleroderma is a umbrella term for a group of autoimmune diseases resulting in changes in blood vessels, skin, muscles, and other organs. The symptoms of Scleroderma include thickened and stiff skin, lethargy, and poor blood flow to extremities of the limbs such as fingers and toes on exposure to co…
世界のアミノグリコシド系抗生物質薬剤市場規模・現状・予測（2021年-2027年） Aminoglycosides are potent bactericidal antibiotics that act by creating fissures in the outer membrane of the bacterial cell. They are particularly active against aerobic, gram-negative bacteria and act synergistically against certain gram-positive organisms. Market Analysis and Insights: Global Am…
世界の小売薬市場規模・現状・予測（2021年-2027年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
世界の抗緑内障薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-glaucoma Drug Market The global Anti-glaucoma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…